Dr. Savita Dandapani, MD – Duarte, CA ...

Dr. Savita Dandapani, MD

Claim this profile

City of Hope Medical Center

Studies Prostate Adenocarcinoma
Studies Lymphoma
8 reported clinical trials
19 drugs studied

Affiliated Hospitals

Image of trial facility.

City Of Hope Medical Center

Image of trial facility.

City Of Hope Comprehensive Cancer Center

Clinical Trials Savita Dandapani, MD is currently running

Image of trial facility.

Radiation Therapy + CAR T-Cell Therapy

for Lymphoma

This early phase I clinical trial evaluates bridging radiation therapy given before chimeric antigen receptor (CAR) T-cell infusion to treat large B-cell lymphoma (LBCL) that has come back (relapsed) or has not responded to previous treatment (refractory). Patients with relapsed or refractory disease have historically poor prognosis. CAR T-cell therapy is a type of treatment in which a patient's T-cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T-cells are taken from a patient's blood (leukapheresis). Then the gene for a special receptor that binds to a certain protein on the patient's cancer cells is added to the T-cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T-cells are grown in the laboratory and given to the patient by infusion for treatment of certain cancers. While the outcomes from CAR T-cell therapy appear favorable, in the time between leukapheresis and CAR T-cell infusion many patients have symptomatic or life-threatening disease which often requires bridging therapy. Bridging therapy aims to slow disease progression and control symptoms during this critical period prior to CAR T-cell infusion. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells. Giving bridging radiation therapy to patients with relapsed or refractory LBCL prior to CAR T-cell infusion may improve treatment outcomes with minimal toxicity.

Recruiting

1 award

Phase < 1

Image of trial facility.

Stereotactic Body Radiation Therapy

for Cancer

This trial uses radiation therapy and a special PET scan to help lymphoma and metastatic solid tumor patients. The radiation attracts immune cells to fight the cancer, and the scan checks if these cells are working properly.

Recruiting

1 award

Phase 1

More about Savita Dandapani, MD

Clinical Trial Related

7 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical Trials

Treatments Savita Dandapani, MD has experience with

  • Stereotactic Body Radiation Therapy
  • Goserelin Acetate
  • Leuprolide Acetate
  • Radium Ra 223 Dichloride
  • Chimeric Antigen Receptor T-Cell Therapy
  • External Beam Radiation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Savita Dandapani, MD specialize in?

Is Savita Dandapani, MD currently recruiting for clinical trials?

Are there any treatments that Savita Dandapani, MD has studied deeply?

What is the best way to schedule an appointment with Savita Dandapani, MD?

What is the office address of Savita Dandapani, MD?

Is there any support for travel costs?